{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:15:49Z","timestamp":1788466549483,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ajog.2020.06.044","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T02:01:25Z","timestamp":1593050485000},"page":"447.e1-447.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacologic intervention for the management of retained placenta: a systematic review and meta-analysis of randomized trials"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-8763","authenticated-orcid":false,"given":"Haylea S.","family":"Patrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-8170","authenticated-orcid":false,"given":"Anjali","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-2595","authenticated-orcid":false,"given":"Cande V.","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.06.044_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2393-14-37","article-title":"Umbilical vein injection of misoprostol versus normal saline for the treatment of retained placenta: intrapartum placebo-controlled trial","volume":"14","author":"Rajab","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2020.06.044_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1447-0756.2012.01974.x","article-title":"Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial","volume":"39","author":"Samanta","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2020.06.044_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(09)61752-9","article-title":"Umbilical vein oxytocin for the treatment of retained placenta (release study): a double-blind, randomised controlled trial","volume":"375","author":"Weeks","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.06.044_bib4","first-page":"863","article-title":"Prolonged third stage of labor: morbidity and risk factors","volume":"77","author":"Combs","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1447-0756.2010.01499.x","article-title":"Intraumbilical injection of three different uterotonics in the management of retained placenta","volume":"37","author":"Harara","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2020.06.044_bib6","first-page":"1039","article-title":"ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage","volume":"108","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib7","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.06.044_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijgo.2005.08.020","article-title":"Sublingual nitroglycerin for management of retained placenta","volume":"91","author":"Bullarbo","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.06.044_bib9","doi-asserted-by":"crossref","first-page":"321207","DOI":"10.1155\/2012\/321207","article-title":"Nitroglycerin for management of retained placenta: a multicenter study","volume":"2012","author":"Bullarbo","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ajog.2020.06.044_bib10","first-page":"1374","article-title":"Umbilical vein injection of misoprostol vs Syntocinon in normal saline for the treatment of retained placenta: randomized control trial","volume":"10","author":"Nazeer","year":"2016","journal-title":"Pak J Med Health Sci"},{"key":"10.1016\/j.ajog.2020.06.044_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/00016340601088570","article-title":"Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta","volume":"86","author":"Rogers","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2020.06.044_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0301-2115(95)02273-2","article-title":"Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta","volume":"64","author":"Bider","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.06.044_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1471-0528.1991.tb13423.x","article-title":"Management of retained placenta by umbilical vein injection","volume":"98","author":"Carroli","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib14","first-page":"13","article-title":"Intraumbilical injection of oxytocin in treatment of retained placenta: our experience","volume":"6","author":"Dizdarevic","year":"2011","journal-title":"Tech Technol Educ Manag"},{"key":"10.1016\/j.ajog.2020.06.044_bib15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0002-9378(87)90372-3","article-title":"The effect of oxytocin injection into the umbilical vein for the management of the retained placenta","volume":"156","author":"Kristiansen","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0020-7292(94)02271-Y","article-title":"Intraumbilical oxytocin for management of retained placenta","volume":"48","author":"Makkonen","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.06.044_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0002-9378(89)90254-8","article-title":"Removing a retained placenta by oxytocin\u2014a controlled study","volume":"161","author":"Wilken-Jensen","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/01443618809008808","article-title":"Intra-umbilical vein oxytocin in the management of retained placenta: a random, prospective, double blind, placebo controlled study","volume":"8","author":"Frappell","year":"1988","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib19","first-page":"3254","article-title":"The effects of sequential use of oxytocin and sublingual nitroglycerin in the cases of retained placenta","volume":"29","author":"Kashanian","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.06.044_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.15296\/ijwhr.2018.49","article-title":"Umbilical vein injection of misoprostol versus oxytocin for managing retained placenta after parturition: a randomized clinical trial","volume":"6","author":"Najafian","year":"2018","journal-title":"Int J Womens Health Reprod Sci"},{"key":"10.1016\/j.ajog.2020.06.044_bib21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jog.12702","article-title":"Carbetocin versus intra-umbilical oxytocin in the management of retained placenta: a randomized clinical study","volume":"41","author":"Elfayomy","year":"2015","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2020.06.044_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0029-7844(97)00622-4","article-title":"Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial","volume":"91","author":"Gazvani","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2001-17037","article-title":"Treatment of a retained placenta with intraumbilical oxytocin injection","volume":"123","author":"Habek","year":"2001","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.ajog.2020.06.044_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijgo.2007.05.007","article-title":"Intraumbilical injection of uterotonics for retained placenta","volume":"99","author":"Habek","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.06.044_bib25","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/0002-9378(91)90685-K","article-title":"Umbilical vein administration of oxytocin for the management of retained placenta: is it effective?","volume":"164","author":"Huber","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00404-010-1785-6","article-title":"Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?","volume":"284","author":"Lim","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.06.044_bib27","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1080\/14767058.2016.1242124","article-title":"Different routes and forms of uterotonics for treatment of retained placenta: a randomized clinical trial","volume":"30","author":"Maher","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.06.044_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.srhc.2019.05.002","article-title":"Intra-umbilical vein injection of carbetocin versus oxytocin in the management of retained placenta","volume":"21","author":"Salem","year":"2019","journal-title":"Sex Reprod Healthc"},{"key":"10.1016\/j.ajog.2020.06.044_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ajog.2005.08.029","article-title":"Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial","volume":"194","author":"van Beekhuizen","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijgo.2013.03.029","article-title":"A\u00a0randomized controlled trial on the value of misoprostol for the treatment of retained placenta in a low-resource setting","volume":"122","author":"van Beekhuizen","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.06.044_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/aogs.12065","article-title":"No reduction of manual removal after misoprostol for retained placenta: a double-blind, randomized trial","volume":"92","author":"van Stralen","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2020.06.044_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2010.08.021","article-title":"Intravenous nitroglycerin for controlled cord traction in the management of retained placenta","volume":"112","author":"Visalyaputra","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.06.044_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tjog.2018.04.002","article-title":"Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: a meta-analysis of randomized controlled trials in cesarean deliveries","volume":"57","author":"Voon","year":"2018","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib34","doi-asserted-by":"crossref","first-page":"e17911","DOI":"10.1097\/MD.0000000000017911","article-title":"Carbetocin vs oxytocin for prevention of postpartum hemorrhage after vaginal delivery: a meta-analysis","volume":"98","author":"Jin","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajog.2020.06.044_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/AOG.0000000000000697","article-title":"Pharmacologic intervention for retained placenta: a systematic review and meta-analysis","volume":"125","author":"Duffy","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.06.044_bib36","doi-asserted-by":"crossref","first-page":"e3082","DOI":"10.1002\/psc.3082","article-title":"Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries","volume":"24","author":"Malm","year":"2018","journal-title":"J\u00a0Pept Sci"},{"key":"10.1016\/j.ajog.2020.06.044_bib37","first-page":"CD001338","article-title":"Oral misoprostol for induction of labour","volume":"2014","author":"Alfirevic","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820306694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820306694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:25:55Z","timestamp":1788463555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820306694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0002937820306694"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.06.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic intervention for the management of retained placenta: a systematic review and meta-analysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}